Pharmacological lipid-modification therapies for prevention of ischaemic heart disease: current and future options

An appraisal of currently available and emerging therapies for lowering LDL cholesterol, lipoprotein(a), and triglycerides for prevention of ischaemic heart disease.
Source: The Lancet

 

Related stories